Cryo-Cell International, Inc.

NYSE American: CCEL    
Share price (4/25/24): $7.80    
Market cap (4/25/24): $63.2 million

Indentures Filter

EX-4.2
from S-1/A 21 pages Cryo-Cell International, Inc. and U.S. Bank Trust Company, National Association, as Trustee First Supplemental Indenture Dated as of [May , 2022] to the Indenture Dated as of [May , 2022] [ ]% Senior Notes Due [20 ]
12/34/56
EX-4.1
from S-1/A 69 pages Cryo-Cell International, Inc. to U.S. Bank Trust Company, National Association as Trustee Indenture Dated as of [ , 2022] Senior Debt Securities
12/34/56
EX-4.1
from 8-K 2 pages Amendment to Rights Agreement
12/34/56
EX-4.1
from 8-K 47 pages Rights Agreement
12/34/56
EX-4.1
from 8-A12G 47 pages Rights Agreement
12/34/56
EX-4.1
from S-8 ~10 pages Cryo-Cell International, Inc. Stock Incentive Plan
12/34/56
EX-4.1
from S-8 1 page Indenture or similar
12/34/56
EX-4.1
from S-8 ~5 pages Indenture or similar
12/34/56
EX-4.1
from S-8 1 page Indenture or similar
12/34/56
EX-4.2
from S-8 1 page S-8 Stock Option Agreement Grantee: Saggi Capital Corp. Address: 575 Lexington Avenue New York, Ny 10022 Option to Purchase: Two Hundred Thousand (200,000) Shares of Cryo-Cell International, Inc. Common Stock Exercise Price Per Share: $1.00 Expiration Date: February 5, 1999 Cryo-Cell International, Inc. (CCEL), (The "Grantor"), Hereby Grants to the Above Named Grantee an Option to Purchase Shares of Its Common Stock at the Purchase Price Above. the Grant of Option(s) Is Pursuant to the Investor Relations Agreement, Dated November 5, 1998 ("Agreement") and Is Subject to All Terms and Conditions Agreed Upon Between the Grantor and Grantee. the Price Per Share and Number of Shares Will Adjusted in the Event of a Stock Split, Stock Dividend, Merger or Consolidation or Other Recapitalization. Unless Otherwise Provided by Rider to the Option Agreement, Signed by Both the Grantor and the Grantee, This Agreement Entitles the Grantee to Purchase the Stock or Any Portion Thereof Within the Specified Ninety (90) Day Period. the Options Granted Hereunder Shall Expire at the End of the Ninety Day Period. the Grantor Will File an SEC Form S-8 Pertaining to These Options. This Option Agreement Is Not Assignable or Transferable. Executed by the Company on This 5th Day of November, 1998. Cryo-Cell International, Inc. By: /S/ Daniel D. Richard Daniel D. Richard, Chairman and Chief Executive Officer the Holder of This Option Hereby Requests the Exercise of This Option. By: Title: Exercise Date: S9
12/34/56
EX-4.1
from S-8 ~5 pages Indenture or similar
12/34/56
EX-4.2
from S-8 1 page Indenture or similar
12/34/56
EX-4.1
from S-8 ~5 pages Indenture or similar
12/34/56
EX-4
from S-8 1 page Indenture or similar
12/34/56
EX-4
from S-8 ~5 pages Indenture or similar
12/34/56